EPINASTINE HYDROCHLORIDE (Somerset Therapeutics, LLC)
Welcome to the PulseAid listing for the EPINASTINE HYDROCHLORIDE drug offered from Somerset Therapeutics, LLC. This Adrenergic Agonists [MoA],Adrenergic Receptor Agonist [EPC],Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Somerset Therapeutics, LLC |
| NON-PROPRIETARY NAME: | EPINASTINE HYDROCHLORIDE |
| SUBSTANCE NAME: | EPINASTINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic Agonists [MoA],Adrenergic Receptor Agonist [EPC],Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-09-14 |
| END MARKETING DATE: | 0000-00-00 |
EPINASTINE HYDROCHLORIDE HUMAN PRESCRIPTION DRUG Details:
| Item Description | EPINASTINE HYDROCHLORIDE from Somerset Therapeutics, LLC |
| LABELER NAME: | Somerset Therapeutics, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/mL) |
| START MARKETING DATE: | 2016-09-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70069-008_42e3df84-3ae4-4391-b747-bff68554a568 |
| PRODUCT NDC: | 70069-008 |
| APPLICATION NUMBER: | ANDA090951 |
Other EPINASTINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
